Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Women's health
MedTech
Organon pays $27.5M upfront for Sebela's hormone-free copper IUD
Organon is grabbing global licensing rights to Sebela's hormone-free copper intrauterine device in a deal potentially worth more than $532 million.
Natalie Missakian
Feb 24, 2026 4:25am
Organon divests Jada System, sends 100 employees to Laborie
Nov 7, 2025 9:05am
Diabetes drug soothes brain inflammation in female mice with MS
Oct 15, 2025 6:16pm
Pivotal, Wellcome Leap invest $100M in women's health research
Sep 10, 2025 10:35am
Senate bill aims to keep NIH, CDC funds intact
Aug 4, 2025 11:30am
J&J trials IVL-first strategy in women with blocked coronaries
May 20, 2025 11:45am
